|
EVC expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.195600E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.537620E-03 |
| Normal-vs-Stage2 |
3.467400E-01 |
| Normal-vs-Stage3 |
9.923200E-01 |
| Normal-vs-Stage4 |
1.997350E-03 |
| Stage1-vs-Stage2 |
1.266230E-01 |
| Stage1-vs-Stage3 |
1.148980E-01 |
| Stage1-vs-Stage4 |
2.30759999997332E-08 |
| Stage2-vs-Stage3 |
5.333400E-01 |
| Stage2-vs-Stage4 |
2.222000E-03 |
| Stage3-vs-Stage4 |
7.246300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.231800E-04 |
| Normal-vs-AfricanAmerican |
3.204400E-01 |
| Normal-vs-Asian |
4.292600E-01 |
| Caucasian-vs-AfricanAmerican |
3.145500E-02 |
| Caucasian-vs-Asian |
2.664000E-01 |
| AfricanAmerican-vs-Asian |
2.447400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.436000E-03 |
| Normal-vs-Female |
2.141700E-02 |
| Male-vs-Female |
2.894200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.600800E-01 |
| Normal-vs-Extreme_Weight |
1.812080E-02 |
| Normal-vs-Obese |
6.815800E-02 |
| Normal-vs-Extreme_Obese |
9.816200E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.282000E-01 |
| Normal_Weight-vs-Obese |
7.514400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.225600E-01 |
| Extreme_Weight-vs-Obese |
8.756200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.245800E-02 |
| Obese-vs-Extreme_Obese |
1.266570E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.317600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.897460E-03 |
| Normal-vs-Age(61-80Yrs) |
2.818400E-02 |
| Normal-vs-Age(81-100Yrs) |
4.077600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.772410E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.309800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.565000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.733800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.695400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.432400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.07639999999709E-05 |
| Normal-VS-Type2 PRCC |
8.342200E-01 |
| Normal-VS-KIRP CIMP |
6.64939999728276E-08 |
| Normal-VS-Unclassified PRCC |
6.310100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.994200E-04 |
| Type1 PRCC-VS-KIRP CIMP |
3.44169137633799E-15 |
| Type1 PRCC-VS-Unclassified PRCC |
5.730400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.77300000020675E-07 |
| Type2 PRCC-VS-Unclassified PRCC |
9.227500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.10029999999839E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.813400E-01 |
| Normal-vs-N1 |
2.963900E-02 |
| Normal-vs-N2 |
2.364200E-02 |
| N0-vs-N1 |
4.499600E-02 |
| N0-vs-N2 |
1.467560E-01 |
| N1-vs-N2 |
4.481200E-01 |
|
|
